Assenagon Asset Management’s 89bio ETNB Stock Holding History

Assenagon Asset Management’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-242,716	Closed	-$3.57M	–	1189
2025 Q3	$3.57M	Sell	242,716 -1,928,478	-89%	-$19.7M	﹤0.01%	688
2025 Q2	$21.3M	Buy	2,171,194 +1,742,299	+406%	+$14.4M	0.03%	340
2025 Q1	$3.12M	Buy	428,895 +186,293	+77%	+$1.63M	0.01%	650
2024 Q4	$1.9M	Buy	+242,602	New	+$2M	﹤0.01%	964
2023 Q4	–	Sell	-317,751	Closed	-$4.91M	–	1430
2023 Q3	$4.91M	Buy	+317,751	New	+$5.33M	0.02%	583

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Assenagon Asset Management's ETNB Position: Q4 2025 in Review

Assenagon Asset Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 242,716 shares — an estimated $3.57M sold.

Assenagon Asset Management first reported a position in ETNB in Q3 2023 and held it in 5 quarters. The position peaked at $21.3M in Q2 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Assenagon Asset Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Assenagon Asset Management sold 242,716 89bio shares in Q4 2025, an estimated $3.57M.
Assenagon Asset Management first reported a position in 89bio in Q3 2023 and held it in 5 quarters.
Assenagon Asset Management's 89bio position peaked at $21.3M in Q2 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Assenagon Asset Management's 13F filing for Q4 2025, filed 9 Jan 2026.